Antiretroviral use for prevention and other factors affecting the course of the HIV-1 epidemic [0.03%]
抗逆转录病毒的使用及其他影响HIV-1流行进程的因素
Susan P Buchbinder
Susan P Buchbinder
Antiretroviral therapy has tremendous potential to alter the HIV-1 epidemic trajectory. However, gaps in the continuum from HIV diagnosis, through linkage to care and uptake and adherence to antiretroviral therapy, are substantially limitin...
David I Watkins
David I Watkins
The 19th Conference on Retroviruses and Opportunistic Infections heralded the arrival of a new crop of potent, broadly neutralizing antibodies against HIV. This advance has given the entire vaccine field enormous hope that it will be possib...
Mario Stevenson
Mario Stevenson
The Conference on Retroviruses and Opportunistic Infections (CROI) is held annually to provide a forum for scientists to hear the most recent advances in the field of HIV and AIDS research. Although the conference has a primary mission to s...
Robert T Schooley
Robert T Schooley
Editorial
Topics in antiviral medicine. 2012 Apr-May;20(1):17-9. DOI: 2012
Kimberly A Workowski
Kimberly A Workowski
Accurate assessment, diagnosis, and treatment of sexually transmitted infections (STIs) in HIV-infected persons can identify sexual risk behaviors and specific STIs that may increase transmission of STIs and HIV. HIV-infected men and women ...
David L Thomas
David L Thomas
Since 2007, the annual age-adjusted mortality rate in hepatitis C virus (HCV) infection in the United States has been greater than that in HIV disease, reflecting the continuing decline in HIV-related mortality and the continuing increase i...
David L McCollum
David L McCollum
The Infectious Diseases Society of America Annual Meeting serves as a time of expert review of the year's most important innovations. Important new information on HIV infection incidence was discussed. The remarkable efficacy of "treatment ...
Connie L Celum
Connie L Celum
HIV preexposure prophylaxis (PrEP) has demonstrated efficacy in 4 studies: 1) the CAPRISA 004 trial of pericoital administration of 1% tenofovir gel showed moderate (39%) efficacy in reducing risk of HIV acquisition in young women; 2) the i...
Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools [0.03%]
临床评价认知障碍：实用筛查和评估工具
Victor G Valcour
Victor G Valcour
HIV-associated neurocognitive disorders (HAND) remain a substantial problem in the era of combination antiretroviral therapy. Neither the Mini Mental State Exam nor the HIV Dementia Scale is sufficiently sensitive for HAND. The Montreal Cog...
Case Reports
Topics in antiviral medicine. 2011 Dec;19(5):175-80. DOI: 2011
Wendy S Post
Wendy S Post
Cardiovascular disease (CVD) is the leading cause of non-HIV-related death in HIV-infected persons. The risk of CVD in HIV-infected persons appears to reflect the contribution of a number of factors, including non-HIV-related (traditional) ...